Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-03

Clinical Trial Update: Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD) [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating oral sodium bicarbonate supplementation in patients with end-stage renal disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Imperial College Healthcare NHS Trust | Conditions: End-stage Renal Disease | Phase 4 | Status: COMPLETED